Chinese english Germany Japanese Korea

N-(1H-1,2,4-triazol-3-yl)-2-[(4,8,8-trimethyl-2-oxo-9,10-dihydro-2H,8H-pyrano[2,3-f]chromen-5-yl)oxy]acetamide

N-(1H-1,2,4-triazol-3-yl)-2-[(4,8,8-trimethyl-2-oxo-9,10-dihydro-2H,8H-pyrano[2,3-f]chromen-5-yl)oxy]acetamide Struktur
939892-37-2
CAS-Nr.
939892-37-2
Englisch Name:
N-(1H-1,2,4-triazol-3-yl)-2-[(4,8,8-trimethyl-2-oxo-9,10-dihydro-2H,8H-pyrano[2,3-f]chromen-5-yl)oxy]acetamide
Synonyma:
N-(1H-1,2,4-triazol-3-yl)-2-[(4,8,8-trimethyl-2-oxo-9,10-dihydro-2H,8H-pyrano[2,3-f]chromen-5-yl)oxy]acetamide;Acetamide, 2-[(9,10-dihydro-4,8,8-trimethyl-2-oxo-2H,8H-benzo[1,2-b:3,4-b']dipyran-5-yl)oxy]-N-1H-1,2,4-triazol-5-yl-
CBNumber:
CB04026381
Summenformel:
C19H20N4O5
Molgewicht:
384.39
MOL-Datei:
939892-37-2.mol
Request For Quotation

N-(1H-1,2,4-triazol-3-yl)-2-[(4,8,8-trimethyl-2-oxo-9,10-dihydro-2H,8H-pyrano[2,3-f]chromen-5-yl)oxy]acetamide Eigenschaften

Sicherheit

N-(1H-1,2,4-triazol-3-yl)-2-[(4,8,8-trimethyl-2-oxo-9,10-dihydro-2H,8H-pyrano[2,3-f]chromen-5-yl)oxy]acetamide Chemische Eigenschaften,Einsatz,Produktion Methoden

N-(1H-1,2,4-triazol-3-yl)-2-[(4,8,8-trimethyl-2-oxo-9,10-dihydro-2H,8H-pyrano[2,3-f]chromen-5-yl)oxy]acetamide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

N-(1H-1,2,4-triazol-3-yl)-2-[(4,8,8-trimethyl-2-oxo-9,10-dihydro-2H,8H-pyrano[2,3-f]chromen-5-yl)oxy]acetamide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
OTAVA chemicals --
 north.america@otavachemicals.com Ukraine 6495 72
VITAS-M LABORATORY, LTD. --
 Russia 6754 64
Interbioscreen Ltd. --
 screen@ibscreen.chg.ru Finland 6178 60
PHARMEKS Ltd. --
 sales@pharmeks.com Finland 6350 50
  • N-(1H-1,2,4-triazol-3-yl)-2-[(4,8,8-trimethyl-2-oxo-9,10-dihydro-2H,8H-pyrano[2,3-f]chromen-5-yl)oxy]acetamide
  • Acetamide, 2-[(9,10-dihydro-4,8,8-trimethyl-2-oxo-2H,8H-benzo[1,2-b:3,4-b']dipyran-5-yl)oxy]-N-1H-1,2,4-triazol-5-yl-
  • 939892-37-2
Copyright 2019 © ChemicalBook. All rights reserved